The field of oncology has undergone rapid changes following the introduction of immunotherapies and biologics. However, these changes have also created new roles for radiology in both diagnosis and treatment. Our article addresses the evolving role of radiology in the immune checkpoint inhibitor era of oncology. With the progression of new immunotherapies for cancer, imaging paradigms and image guided therapy options have changed. Multidisciplinary oncology teams should be aware of these opportunities for collaboration.
Keywords: Immune checkpoint inhibitors; Immune related adverse events; Interventional oncology; Oncologic imaging.
Copyright © 2024 Elsevier Inc. All rights reserved.